Metformin–a potentially effective drug for gestational diabetes mellitus: a systematic review and meta-analysis

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 30, Issue 15, 2017, Pages 1874-1881

  Feng, Ye ^a   Yang, Huixia ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

gestational diabetes mellitus; insulin; meta analysis; Metformin

Indexed keywords

GLIBENCLAMIDE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; ANTIDIABETIC AGENT;

ADULT; ARTICLE; CESAREAN SECTION; CONTROLLED STUDY; DRUG SAFETY; FEMALE; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN RELEASE; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS SYNDROME; SYSTEMATIC REVIEW; WEIGHT GAIN; BIRTH WEIGHT; BLOOD; BODY WEIGHT GAIN; FETOMATERNAL TRANSFUSION; PREGNANCY;

BIRTH WEIGHT; DIABETES, GESTATIONAL; FEMALE; GESTATIONAL AGE; GLYCATED HEMOGLOBIN A; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MATERNAL-FETAL EXCHANGE; METFORMIN; PREGNANCY; WEIGHT GAIN;

EID: 84986182370     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767058.2016.1228061     Document Type: Article

References (39)

1. Unwin N., IDF diabetes atlas. IDF Executive Office:2009
2. Zhang C, Ning Y., Effect of dietary and lifestyle factors on the risk of gestational diabetes:review of epidemiologic evidence. Am J Clin Nutr 2011;94:1975S–9
3. Bottalico JN., In recurrent gestational diabetes:risk factors, diagnosis, management, and implications. Semin Perinatol 2007;31:176–84
4. Zhu W, Yang H, Wei Y, et al. Comparing the diagnostic criteria for gestational diabetes mellitus of World Health Organization 2013 with 1999 in Chinese population. Chin Med J 2015;128:125
5. Feig DS, Zinman B, Wang X, Hux JE., Risk of development of diabetes mellitus after diagnosis of gestational diabetes. Can Med Assoc J 2008;179:229–34
6. Ma RC, Tutino GE, Lillycrop KA, et al. Maternal diabetes, gestational diabetes and the role of epigenetics in their long term effects on offspring. Prog Biophys Mol Biol 2015;118:55–68
7. Barahona MJ, Sucunza N, García-Patterson A, et al. Period of gestational diabetes mellitus diagnosis and maternal and fetal morbidity. Acta Obstetricia Et Gynecologica Scandinavica 2005;84:622–7
8. Catalano PM, Kirwan JP, Haugel-de Mouzon S, King J. Gestational diabetes and insulin resistance:role in short- and long-term implications for mother and fetus. J Nutr 2003;133:1674S–83
9. Cunningham FG., Williams Obstetrics 24th edition McGraw-Hill Education. Medical:2014
10. Hod M, Kapur A, Sacks DA, et al. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus:a pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet 2015;131:S173
11. Bertoldo MJ, Faure M, Dupont J, Froment P., Impact of metformin on reproductive tissues:an overview from gametogenesis to gestation. Ann Transl Med 2014;2:55
12. Elliott B, Langer O, Schuessling F., Human placental glucose uptake and transport are not altered by the oral antihyperglycemic agent metformin. Am J Obstet Gynecol 1997;176:527–30
13. Dabelea D., The predisposition to obesity and diabetes in offspring of diabetic mothers. Diabetes Care 2007;30:S169–74
14. Rowan JA, Hague WM, Gao W, et al. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 2008;358:2003–15
15. Ijäs H, Vääräsmäki M, Morin-Papunen L, et al. Metformin should be considered in the treatment of gestational diabetes:a prospective randomized study. BJOG 2011;118:880–5
16. Niromanesh S, Alavi A, Sharbaf FR, et al. Metformin compared with insulin in the management of gestational diabetes mellitus:a randomized clinical trial. Diabetes Res Clin Pract 2012;98:422–9
17. Mesdaghinia E, Samimi M, Homaei Z, et al. Comparison of newborn outcomes in women with gestational diabetes mellitus treated with metformin or insulin:a randomised blinded trial. Int J Prev Med 2013;4:327
18. Spaulonci CP, Bernardes LS, Trindade TC, et al. Randomized trial of metformin vs insulin in the management of gestational diabetes. Am J Obstet Gynecol 2013;209:34. e1–7
19. Barrett HL, Gatford KL, Houda CM, et al. Maternal and neonatal circulating markers of metabolic and cardiovascular risk in the metformin in gestational diabetes (MiG) trial responses to maternal metformin versus insulin treatment. Diabetes Care 2013;36:529–36
20. Barrett HL, Nitert MD, Jones L, et al. Determinants of maternal triglycerides in women with gestational diabetes mellitus in the metformin in gestational diabetes (MiG) study. Diabetes Care 2013;36:1941–6
21. Gatford K, Houda C, Lu ZX, et al. Vitamin B12 and homocysteine status during pregnancy in the metformin in gestational diabetes trial:responses to maternal metformin compared with insulin treatment. Diabetes Obes Metab 2013;15:660–7
22. Ibrahim MI, Hamdy A, Shafik A, et al. The role of adding metformin in insulin-resistant diabetic pregnant women:a randomized controlled trial. Arch Gynecol Obstet 2014;289:959–65
23. Tertti K, Ekblad U, Koskinen P, et al. Metformin vs. insulin in gestational diabetes. A randomized study characterizing metformin patients needing additional insulin. Diabetes Obes Metab 2013;15:246–51
24. Tertti K, Laine K, Ekblad U, et al. The degree of fetal metformin exposure does not influence fetal outcome in gestational diabetes mellitus. Acta Diabetol 2014;51:731–8
25. Ainuddin J, Karim N, Hasan AA, Naqvi SA., Metformin versus insulin treatment in gestational diabetes in pregnancy in a developing country. A randomized control trial. Diabetes Res Clin Prac 2015;107:290–9
26. Balani J, Hyer S, Rodin D, Shehata H. Pregnancy outcomes in women with gestational diabetes treated with metformin or insulin:a case-control study. Diabet Med 2009;26:798–802
27. Gandhi P, Bustani R, Madhuvrata P, Farrell T., Introduction of metformin for gestational diabetes mellitus in clinical practice:has it had an impact? Eur J Obstet Gynecol Reprod Biol 2012;160:147–50
28. Goh J, Sadler L, Rowan J., Metformin for gestational diabetes in routine clinical practice. Diabet Med 2011;28:1082–7
29. Rai L, Meenakshi D, Kamath A., Metformin-A convenient alternative to insulin for Indian women with diabetes in pregnancy. Indian J Med Sci 2009;63:491
30. Tertti K, Ekblad U, Vahlberg T, Rönnemaa T., Comparison of metformin and insulin in the treatment of gestational diabetes:a retrospective, case-control study. Rev Diabet Stud 2008;5:95
31. Nanovskaya TN, Nekhayeva IA, Patrikeeva SL, et al. Transfer of metformin across the dually perfused human placental lobule. Am J Obstet Gynecol 2006;195:1081–5
32. Gui J, Liu Q, Feng L., Metformin vs insulin in the management of gestational diabetes:a meta-analysis. PLoS One 2013;8:e64585
33. Lamanna C, Monami M, Marchionni N, Mannucci E., Effect of metformin on cardiovascular events and mortality:a meta-analysis of randomized clinical trials. Diabetes Obes Metab 2011;13:221–8
34. Gilbert C, Valois M, Koren G., Pregnancy outcome after first-trimester exposure to metformin:a meta-analysis. Fertil Steril 2006;86:658–63
35. Shahine L, Lathi RB, Dahan MH., Metformin and fetal malformations. Fertil Steril 2007;87:1240
36. Lautatzis ME, Goulis DG, Vrontakis M., Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome:a systematic review. Metab Clin Exp 2013;62:1522–34
37. Chiswick C, Reynolds RM, Denison F, et al. Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR):a randomized, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol 2015;3:778–86
38. Smith J, Sallman MA, Berens P, et al. 658:Metformin improved lipid profiles in women with gestational diabetes in the first six weeks postpartum. Am J Obstet Gynecol 2015;212:S324
39. Huang NL, Chiang SH, Hsueh CH, et al. Metformin inhibits TNF-α-induced IκB kinase phosphorylation, IκB-α degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation. Int J Cardiol 2009;134:169–75